Abstract
Purpose. The specific activities of the purine and pyrimidine metabolizing enzymes, purine nucleoside phosphorylase (PNP), adenosine deaminase (ADA) and cytidine deaminase (CDA) were determined in bovine brain microvessel endothelial cells (BBMECs), whole cerebral tissue and erythrocytes. In addition, the substrate specificities (Km and Vmax) of purified calf spleen PNP for inosine and 2′,3′-dideoxyinosine (ddl) and of purified calf intestinal ADA for 2′,3′-dideoxyadenosine (ddA), 6-chloro-2′,3′-dideoxypurine (6-Cl-ddP), and 2′-β-fluoro-2′,3′-dideoxyadenosine (F-ddA) have been explored.
Methods. BBMECs were isolated from bovine cerebral cortex by a two step enzymatic dispersion treatment followed by centrifugation over 50% Percoll density gradients. Activities of alkaline phosphatase, γ-glutamyl transpeptidase, ADA, PNP and CDA were determined in various tissue homogenates (cerebral cortex, BBMECs and erythrocytes). Enzyme kinetic studies were also conducted using commercially available enzymes and several nucleoside analogs of interest.
Results. The activities of ADA and PNP were 42-fold and 247-fold higher in the cerebral microvessels than in the cerebral cortex, respectively, while there was no detectable CDA activity in the microvessel fraction and very little overall activity in the cortex.
Conclusions. ADA and PNP may serve as an enzymatic blood-brain barrier for some of the anti-HIV dideoxynucleosides. Simulations of brain availability for ddl, ddA, 6-Cl-ddP, and F-ddA demonstrated that the quantitative significance of enzyme localization may vary dramatically, however, depending on the membrane permeability of the drug and its bioconversion rate constant within the endothelial cell.
Similar content being viewed by others
REFERENCES
W. M. Pardridge. Physiol. Rev. 63:1481–1535 (1983).
J. E. Hardebo, B. Falck, C. Owman and E. Rosengren. Acta Physiol. Scand. 105:453–460 (1979).
J. F. Ghersi-Egea, B. Leninger-Muller, G. Suleman, G. Siest and A. Minn. J. Neurochem. 62:1089–1096 (1994).
A. Minn, J.-F. Ghersi-Egea, R. Perrin, B. Leininger and G. Siest. Brain Res. Rev. 16:65–82 (1991).
D. J. Back, S. Ormesher, J. F. Tjia and R. Macleod. Br. J. Clin. Pharmacol. 33:319–322 (1992).
G. S. Ahluwalia, D. A. Cooney, T. Shirasaka, H. Mitsuya, J. S. Driscoll and D. G. Johns. Mol. Pharmacol. 46:1002–1008 (1994).
B. D. Anderson, B. L. Hoesterey, D. C. Baker and R. E. Galinsky. J. Pharmacol. Exp. Ther. 253:113–118. (1990).
D. Singhal, M. E. Morgan and B. D. Anderson. to be submitted (1996).
R. W. Price and B. J. Brew. J. Infect. Dis. 158:1079–1083 (1988).
B. D. Anderson, R. E. Galinsky, D. C. Baker, S.-C. Chi, B. L. Hoesterey, M. E. Morgan, K. Murakami and H. Mitsuya. J. Control. Rel. 19:219–230 (1992).
K. Shanmuganathan, T. Koudriakova, S. Nampalli, J. Du, J. M. Gallo, R. F. Schinazi and C. K. Chu. J. Med. Chem. 37:821–827 (1994).
K. L. Audus and R. T. Borchardt. Pharm. Res. 3:81–87 (1986).
S. T. Williams, J. F. Gillis, M. A. Matthews, R. C. Wagner and M. W. Bitensky. J. Neurochem. 32:374–381 (1980).
G. W. Goldstein, J. S. Wolinsky, J. Csejtey and I. Diamond. J. Neurochem. 25:715–717 (1975).
G. L. Peterson. Anal. Biochem. 83:346–356 (1977).
M. Orlowski and A. Meister. J. Biol. Chem. 240:338–347 (1965).
I. T. James, K. Herbert, D. Perrett and P. W. Thompson. J. Chromatogr. 495:105–112 (1989).
J. D. Stoeckler, C. Cambor and R. E. Parks, Jr. Biochem. 19:102–107 (1980).
C. L. Zielke and C. H. Suelter. In P. D. Boyer, (ed.) The Enzymes, vol. 4, Academic, London, 1971, pp. 47–78.
B. M. Chassy and R. J. Suhadolnik. J. Biol. Chem. 242:3655–3658 (1967).
T. Shirasaka, K. Watanabe, H. Yoshioka, E. Kojima, S. Aoki, K. Murakami and H. Mitsuya. In A. Kumar, (ed.) Advances in Molecular Biology and Targeted Treatment for AIDS, Plenum Press, New York, 1991, pp. 323–333.
G. Giusti, C. Mangoni, B. De Petrocellis and E. Scarano. Enzym. Biol. Clin. 11:375–383 (1970).
S. I. Rapoport, K. Ohno and K. D. Pettigrew. Brain Res. 172:354–359 (1979).
W. M. Pardridge. Peptide Drug Delivery to the Brain, Raven Press, New York, 1991.
F. M. Balis, P. A. Pizzo, K. M. Butler, M. E. Hawkins, P. Brouwers, R. N. Husson, F. Jacobsen, S. M. Blaney, J. Gress, P. Jarosinski and D. G. Poplack. J. Infect. Dis. 165:99–104 (1992).
K. M. Butler, R. N. Husson, F. M. Balis, P. Brouwers, J. Eddy, D. El-Amin, J. Gress, M. Hawkins, P. Jarosinski, H. Moss, D. Poplack, S. Santacroce, D. Venzon, L. Wiener, P. Wolters, P. A. Pizzo. New Engl. J. Med. 324:137–144 (1991).
T. G. Brady and C. I. O'Donovan. Comp. Biochem. Physiol. 14:101–120 (1965).
D. H. W. Ho, C. Pincus, C. J. Carter, R. S. Benjamin, E. J. Freireich and S. Bodey, G. P. Cancer Treat. Rep. 64:629–633 (1980).
J. J. Barchi, Jr., V. E. Marquez, J. S. Driscoll, H. Ford, Jr., H. Mitsuya, T. Shirasaka, S. Aoki and J. A. Kelley. J. Med. Chem. 34:1647–1655 (1991).
T. Shirasaka, K. Murakami, H. Ford, J. A. Kelly, H. Yoshioka, E. Kojima, S. Aoki, S. Broder and H. Mitsuya. Proc. Natl. Acad. Sci. USA 87:9426–9430 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnson, M.D., Anderson, B.D. Localization of Purine Metabolizing Enzymes in Bovine Brain Microvessel Endothelial Cells: An Enzymatic Blood-Brain Barrier for Dideoxynucleosides?. Pharm Res 13, 1881–1886 (1996). https://doi.org/10.1023/A:1016001712524
Issue Date:
DOI: https://doi.org/10.1023/A:1016001712524